Table 3 Effect of atosiban in different endometrium preparation regimens on pregnancy outcomes.
From: Efficacy of atosiban for repeated implantation failure in frozen embryo transfer cycles
Variable | Natural cycle | HRT cycle | Suppression HRT cycle | Ovarion induction cycle | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Group A (n = 187) | Group B (n = 270) | P value | Group A (n = 194) | Group B (n = 322) | P value | Group A (n = 168) | Group B (n = 299) | P value | Group A (n = 128) | Group B (n = 206) | P value | |
Clinical pregnancy rate | 99/187 (52.9%) | 133/270 (49.3%) | 0.448 | 102/194 (52.6%) | 171/322 (53.1%) | 0.758 | 78/168 (46.4%) | 154/299 (51.5%) | 0.335 | 68/128 (53.1%) | 89/206 (43.2%) | 0.091 |
Clinical miscarriage rate | 17/99 (17.2%) | 20/133 (15.0%) | 0.718 | 23/102 (22.5%) | 41/171 (24.0%) | 0.883 | 19/78 (24.4%) | 29/154 (18.8%) | 0.391 | 19/68 (27.9%) | 17/89 (19.1%) | 0.250 |
Ectopic pregnancy rate | 1/99 (1.0%) | 0 | 0.268 | 0 | 1/171 (0.6%) | 1 | 0 | 1/154 (0.6%) | 1 | 0 | 1/89 (1.1%) | 1 |
Preterm birth rate | 0 | 8/270 (3.0%) | 0.024 | 11/194 (5.7%) | 18/322 (5.6%) | 1 | 7/168 (4.2%) | 11/299 (3.7%) | 0.806 | 2/128 (1.6%) | 9/206 (4.4%) | 0.215 |
Live birth rate | 81/187 (43.3%) | 112/270 (41.5%) | 0.701 | 80/194 (41.2%) | 128/322 (39.8%) | 0.781 | 59/168 (35.1%) | 120/299 (40.1%) | 0.322 | 49/128 (38.3%) | 68/206 (33.0%) | 0.347 |
